Welcome to the

Welcome to the

Oligonucleotide Therapeutics Society

The Oligonucleotide Therapeutics Society (OTS) is an open, nonprofit forum to foster research and development of oligonucleotide therapeutics. The Founders’ vision was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities.

Oligonucleotide therapeutics are now being used to successfully treat diseases and have the potential for widespread application. Over 100 treatments are in development for common conditions, including cancer and Alzheimer’s disease, as well as rare diseases. Incredibly, oligonucleotide therapeutics have also been used to create an individualized treatment for one single person with a rare, fatal disease.

All the latest news

FEATURED ARTICLE

Clinical Trials Begin for Ultra-Rare Treatment of Alexander Disease

FEATURED ARTICLE

Facts about COVID-19 mRNA Vaccines and the Decades of Research That Went into Creating Them

Looking back… Looking forward

December 24th, 2021|

This will be my last contribution that I write as President of our Society. On January 1st, 2022, I [...]

Recent Articles

Featured Member

Vasant Jadhav, PhD

Vasant Jadhav, PhD.
SVP Head of RNAi Platform
Alnylam Pharmaceuticals

During undergrad, I was intrigued by the molecular machines and mechanisms behind secrets of life- replication, transcription, and translation. Understanding nature’s language and redirecting it for applied research seemed like super cool idea!

Read More

Become a Member

Membership is an opportunity to take advantage of an array of benefits that support the society’s mission to foster academia and industry-based research and development of oligonucleotide therapeutics, all at a reasonable rate!

Register

Award & Travel Grants

The Oligonucleotide Therapeutics Society offers the opportunity for both members and non-members to apply for various awards to support the accomplishments of students, postdocs and young investigators.

Learn More

Webinars

webinars

A Conversation with OTS President, Prof. David Corey

Past Webinars

Job Board

If you are looking for great people in the field of oligonucleotide therapeutics, we encourage you to post your job openings on our job board. It’s free to post!  Just register as an employer and start posting your openings.

View Job Openings

11 Jobs Found
Displayed Here: 1 - 5 Jobs

  • RSS Feed

Employers

The OTS Job Board allows you to, Post/Edit Jobs Review/Filter Resumes Manage Employer Profiles

Employer Login

Job Seeker

Search the latest job postings in the field of oligonucleotide therapeutics. The OTS Job Board allows you to: Search Jobs Upload your Resume Create Job Alerts

Job Postings

View the 2022-2023 OTS Board of Directors!

...Click on the link below to view the profiles of your elected directors, including their personal motivations, biographies, and affiliations.
https://t.co/qycb3xC4rL

#oligotherapeutics #oligonucleotide #OTS #BoardofDirectors

It's not too late to register for today's webinar... at 11am EST! Join us for an open discussion on the future of the OTS. Prof. David Corey will share his vision for, & answer questions about the OTS.

Register now!
https://t.co/eAYHX8chKs

#OTS #Oligotherapeutics #Oligonucleotides

Join us, tomorrow, January 13th, for an open ...discussion on the future of the OTS. Prof. David Corey will share his vision for, and answer questions about the OTS.

Register today!
https://t.co/eAYHX8tT92

#OTS #Oligotherapeutics #Oligonucleotides #Webinar

Join us, Thursday, January 13th, for an open ...discussion on the future of the OTS. Prof. David Corey will share his vision for, and answer questions about the OTS.

Register now at the link below!
https://t.co/aAVF4wEOHd

#OTS #Oligotherapeutics #Oligonucleotides #Webinar

Clinical Trials Begin for Ultra-Rare Treatment of... Alexander Disease

⬇️

#oligotherapeutics #oligonucleotide #OTS #alexanderdisease #neurologicaldisorder #leukodystrophy @ionispharma

Image for twitter card

Clinical Trials Begin for Ultra-Rare Treatment of Alexander Disease

There is currently no treatment to slow or halt disease progression, but proactive, comprehensive medical care is he...

www.oligotherapeutics.org

Subscribe to our Newsletter

Thank you for Subscribing to our Newsletter.
There was an error trying to send your message. Please try again later.